# Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL

> **NCT00477945** · PHASE1 · COMPLETED · sponsor: **Indiana University** · enrollment: 18 (actual)

## Conditions studied

- Non Hodgkin's Lymphoma

## Interventions

- **DRUG:** clofarabine

## Key facts

- **NCT ID:** NCT00477945
- **Lead sponsor:** Indiana University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2014-09-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00477945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00477945, "Phase I Trial of Clofarabine in Combo w/ HD Etoposide & Cyclophosphamide and APBSCT for Pts w/ High-Risk or Refractory NHL". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00477945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*